Deficiency of histone variant macroH2A1.1 is associated with sexually dimorphic obesity in mice.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
05 11 2023
05 11 2023
Historique:
received:
08
05
2023
accepted:
30
10
2023
medline:
7
11
2023
pubmed:
6
11
2023
entrez:
5
11
2023
Statut:
epublish
Résumé
Obesity has a major socio-economic health impact. There are profound sex differences in adipose tissue deposition and obesity-related conditions. The underlying mechanisms driving sexual dimorphism in obesity and its associated metabolic disorders remain unclear. Histone variant macroH2A1.1 is a candidate epigenetic mechanism linking environmental and dietary factors to obesity. Here, we used a mouse model genetically depleted of macroH2A1.1 to investigate its potential epigenetic role in sex dimorphic obesity, metabolic disturbances and gut dysbiosis. Whole body macroH2A1 knockout (KO) mice, generated with the Cre/loxP technology, and their control littermates were fed a high fat diet containing 60% of energy derived from fat. The diet was administered for three months starting from 10 to 12 weeks of age. We evaluated the progression in body weight, the food intake, and the tolerance to glucose by means of a glucose tolerance test. Gut microbiota composition, visceral adipose and liver tissue morphology were assessed. In addition, adipogenic gene expression patterns were evaluated in the visceral adipose tissue. Female KO mice for macroH2A1.1 had a more pronounced weight gain induced by high fat diet compared to their littermates, while the increase in body weight in male mice was similar in the two genotypes. Food intake was generally increased upon KO and decreased by high fat diet in both sexes, with the exception of KO females fed a high fat diet that displayed the same food intake of their littermates. In glucose tolerance tests, glucose levels were significantly elevated upon high fat diet in female KO compared to a standard diet, while this effect was absent in male KO. There were no differences in hepatic histology. Upon a high fat diet, in female adipocyte cross-sectional area was larger in KO compared to littermates: activation of proadipogenic genes (ACACB, AGT, ANGPT2, FASN, RETN, SLC2A4) and downregulation of antiadipogenic genes (AXIN1, E2F1, EGR2, JUN, SIRT1, SIRT2, UCP1, CCND1, CDKN1A, CDKN1B, EGR2) was detected. Gut microbiota profiling showed increase in Firmicutes and a decrease in Bacteroidetes in females, but not males, macroH2A1.1 KO mice. MacroH2A1.1 KO mice display sexual dimorphism in high fat diet-induced obesity and in gut dysbiosis, and may represent a useful model to investigate epigenetic and metabolic differences associated to the development of obesity-associated pathological conditions in males and females.
Identifiants
pubmed: 37926763
doi: 10.1038/s41598-023-46304-8
pii: 10.1038/s41598-023-46304-8
pmc: PMC10625986
doi:
Substances chimiques
Glucose
IY9XDZ35W2
Histones
0
Macroh2a1 protein, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
19123Informations de copyright
© 2023. The Author(s).
Références
Genes (Basel). 2017 Dec 05;8(12):
pubmed: 29206173
Mol Cell. 2018 Jan 4;69(1):36-47.e7
pubmed: 29249653
Stem Cells. 2022 Mar 3;40(1):35-48
pubmed: 35511867
PLoS One. 2013 Apr 08;8(4):e60527
pubmed: 23593233
Cell Metab. 2019 Apr 2;29(4):932-949.e4
pubmed: 30639359
Cancer Res. 2016 Feb 1;76(3):594-606
pubmed: 26772755
Am J Clin Oncol. 2018 Sep;41(9):874-881
pubmed: 28537989
JAMA. 2015 Sep 8;314(10):1021-9
pubmed: 26348752
Cell Death Dis. 2016 Dec 8;7(12):e2518
pubmed: 27929534
Mol Cell Biol. 2007 Apr;27(7):2758-64
pubmed: 17242180
Nat Commun. 2018 Apr 18;9(1):1544
pubmed: 29670083
Hepatology. 2018 Feb;67(2):636-650
pubmed: 28913935
Cancers (Basel). 2019 May 15;11(5):
pubmed: 31096699
Mol Metab. 2018 Sep;15:35-44
pubmed: 29706320
Int J Obes (Lond). 2015 Sep;39(9):1339-48
pubmed: 25971926
Epigenetics Chromatin. 2016 Oct 25;9:45
pubmed: 27800025
Nat Struct Mol Biol. 2017 Nov;24(11):902-910
pubmed: 28991266
Mol Cell Biol. 2010 Dec;30(23):5473-83
pubmed: 20937776
Microbiome. 2017 Apr 8;5(1):43
pubmed: 28390422
Endocr Rev. 2016 Jun;37(3):278-316
pubmed: 27159875
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Genes Dev. 2010 Jan 1;24(1):21-32
pubmed: 20008927
Genome Res. 2006 Aug;16(8):995-1004
pubmed: 16825664
Endocrinology. 2012 Dec;153(12):5796-808
pubmed: 23064015
FASEB J. 2015 May;29(5):1676-87
pubmed: 25526730
Am J Physiol Cell Physiol. 2022 Aug 01;323(2):C354-C366
pubmed: 35759435
Nat Commun. 2018 Dec 3;9(1):5143
pubmed: 30510186
Front Med (Lausanne). 2022 Jun 16;9:910561
pubmed: 35783625
J Cell Biol. 2000 Sep 4;150(5):1189-98
pubmed: 10974005
Nature. 1998 Jun 11;393(6685):599-601
pubmed: 9634239
Mol Cell Biol. 2009 Jan;29(1):150-6
pubmed: 18936163
Mol Metab. 2020 Aug;38:100925
pubmed: 31992511
PLoS One. 2017 Sep 21;12(9):e0185196
pubmed: 28934364
Epigenetics. 2018;13(8):829-845
pubmed: 30165787
Microorganisms. 2020 Nov 01;8(11):
pubmed: 33139627
Int J Mol Sci. 2019 May 13;20(9):
pubmed: 31085992
Nutrients. 2020 Oct 20;12(10):
pubmed: 33092019
Mol Cell. 2020 Sep 3;79(5):836-845.e7
pubmed: 32649884
Atherosclerosis. 2000 Feb;148(2):231-41
pubmed: 10657558
Mol Cell Endocrinol. 2015 Feb 15;402:113-9
pubmed: 25578600
BMC Med. 2023 Aug 23;21(1):317
pubmed: 37612641
Appl Physiol Nutr Metab. 2019 Jul;44(7):687-695
pubmed: 30500266
Biochem Soc Trans. 2014 Oct;42(5):1409-13
pubmed: 25233423
Cell Metab. 2019 May 7;29(5):1028-1044
pubmed: 30982733
Commun Biol. 2022 Jan 11;5(1):26
pubmed: 35017640
PLoS Genet. 2012;8(5):e1002709
pubmed: 22589744
Science. 2019 Sep 27;365(6460):1428-1434
pubmed: 31604271
Nucleic Acids Res. 1999 Sep 15;27(18):3685-9
pubmed: 10471737
Epigenetics Chromatin. 2010 Apr 01;3(1):8
pubmed: 20359320
Sci Rep. 2017 Aug 15;7(1):8205
pubmed: 28811491
Cell Commun Signal. 2021 Apr 8;19(1):44
pubmed: 33832488
Cancers (Basel). 2021 Jun 15;13(12):
pubmed: 34203934
Cell Rep. 2016 Feb 9;14(5):1156-1168
pubmed: 26832413
Curr Opin Clin Nutr Metab Care. 2015 Sep;18(5):515-20
pubmed: 26154278
Antioxid Redox Signal. 2021 Feb 1;34(4):335-349
pubmed: 32567336
Nature. 2020 Oct;586(7827):108-112
pubmed: 32731255
Diabetes. 2009 Apr;58(4):803-12
pubmed: 19136652
J Cell Biol. 1999 Dec 27;147(7):1399-408
pubmed: 10613899
Mol Med. 2020 Dec 9;26(1):127
pubmed: 33297945
Nat Rev Gastroenterol Hepatol. 2018 Nov;15(11):699-714
pubmed: 30323319
Nucleic Acids Res. 2021 Aug 20;49(14):8024-8036
pubmed: 34223906
Lancet. 2014 Jun 7;383(9933):1990-8
pubmed: 24630777
Int J Obes (Lond). 2015 Feb;39(2):331-8
pubmed: 24849394
Arterioscler Thromb Vasc Biol. 2021 Jun;41(6):e299-e313
pubmed: 33761762
ISME J. 2014 Feb;8(2):295-308
pubmed: 24030595
Dis Model Mech. 2009 Sep-Oct;2(9-10):508-15
pubmed: 19692579
J Cell Sci. 2017 May 1;130(9):1570-1582
pubmed: 28283545
Biol Sex Differ. 2018 Oct 22;9(1):46
pubmed: 30343673
Nat Rev Mol Cell Biol. 2017 May;18(5):299-314
pubmed: 28144029
FASEB J. 2021 Aug;35(8):e21793
pubmed: 34320234
PLoS One. 2011 Jan 07;6(1):e15960
pubmed: 21249133
J Mol Cell Biol. 2017 Aug 1;9(4):325-337
pubmed: 28992292
BMC Cancer. 2019 Jul 12;19(1):684
pubmed: 31299933
Am J Physiol Endocrinol Metab. 2009 May;296(5):E1120-32
pubmed: 19208855
Aging (Albany NY). 2014 Jan;6(1):35-47
pubmed: 24473773
Clin Epigenetics. 2019 Aug 22;11(1):121
pubmed: 31439048
Physiol Behav. 2017 Jul 1;176:174-182
pubmed: 28284880
J Cell Sci. 2022 Apr 1;135(7):
pubmed: 35362516
Front Microbiol. 2017 Jun 22;8:1157
pubmed: 28690599